When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease

When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease

Alzheimer’s disease (AD) is a mostly sporadic brain disorder characterized by cognitive decline resulting from selective neurodegeneration in the hippocampus and cerebral cortex whereas Huntington’s disease (HD) is a monogenic inherited disorder characterized by motor abnormalities and psychiatric d...

Full description

Bibliographic Details
Main Author: Santosh R. D’Mello
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
neurodegenerative diseases
cell cycle
Tau
Aβ
huntingtin
neuroinflammation
Online Access:https://www.mdpi.com/1422-0067/22/11/5911

Internet

https://www.mdpi.com/1422-0067/22/11/5911

Similar Items